Incyte INCY
NASDAQ INCY
$122.27 +1.97 (+1.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Incyte (INCY) Non-Current Deferred Revenue (2009 - 2015)

Updated

Analysis

Incyte (INCY) Non-Current Deferred Revenue (2009 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Incyte 245.42 Mn -15.74 Bn 1.45 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 15.07 Mn
Sep 30, 2015 2.87 Mn
Jun 30, 2015 6.08 Mn
Mar 31, 2015 9.30 Mn
Dec 31, 2014 12.51 Mn
Sep 30, 2014 15.73 Mn
Jun 30, 2014 18.94 Mn
Mar 31, 2014 22.15 Mn
Dec 31, 2013 25.37 Mn
Sep 30, 2013 28.58 Mn
Jun 30, 2013 31.80 Mn
Mar 31, 2013 35.01 Mn
Dec 31, 2012 38.23 Mn
Sep 30, 2012 54.06 Mn
Jun 30, 2012 70.80 Mn
Mar 31, 2012 87.54 Mn
Dec 31, 2011 104.27 Mn
Sep 30, 2011 121.01 Mn
Jun 30, 2011 137.75 Mn
Mar 31, 2011 154.48 Mn
API Access

Incyte Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=INCY&period=max&api_key=YOUR_API_KEY